Aurobindo has seen intense scrutiny on the manufacturer process of valsartan, an anti-hypertension drug, that was found to contain carcinogenic impurities. Apart from Aurobindo, those impurities were detected in several other batches manufactured by drug makers.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2pxczd9
via IFTTT
0 comments:
Post a Comment